Is Revolve Group Stock a Buy, Sell or Hold?
Recently, Revolve Group (NYSE:RVLV) management delivered some fairly positive business…
Sell
36
ELV Quote, Financials, Valuation and Earnings
Last price:
$439.62
Seasonality move
:
3.93%
Day range:
$431.73 - $442.47
52-week range:
$362.21 - $567.26
Dividend yield:
1.5%
P/E ratio:
17.17x
P/S ratio:
0.58x
P/B ratio:
2.42x
Volume:
1.4M
Avg. volume:
1.8M
1-year change:
-12.38%
Market cap:
$100B
Revenue:
$176.8B
EPS (TTM):
$25.61
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
ELV
Elevance Health
|
$46.2B | $11.21 | 8.66% | 12.94% | $507.81 |
|
CI
The Cigna Group
|
$60.3B | $6.35 | 2.02% | 31.91% | $364.13 |
|
CLOV
Clover Health Investments
|
$466.9M | -$0.07 | 34.59% | -75% | $4.75 |
|
CNC
Centene
|
$43.2B | $2.48 | 7.84% | 1% | $79.66 |
|
MOH
Molina Healthcare
|
$10.8B | $5.95 | 9.4% | 16.06% | $346.35 |
|
UNH
UnitedHealth Group
|
$111.6B | $7.31 | 13.76% | 65.02% | $635.32 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
ELV
Elevance Health
|
$439.81 | $507.81 | $100B | 17.17x | $1.71 | 1.5% | 0.58x |
|
CI
The Cigna Group
|
$330.19 | $364.13 | $90.4B | 26.98x | $1.51 | 1.73% | 0.38x |
|
CLOV
Clover Health Investments
|
$3.68 | $4.75 | $1.9B | -- | $0.00 | 0% | 1.37x |
|
CNC
Centene
|
$63.86 | $79.66 | $31.7B | 10.23x | $0.00 | 0% | 0.21x |
|
MOH
Molina Healthcare
|
$345.00 | $346.35 | $19.1B | 16.89x | $0.00 | 0% | 0.49x |
|
UNH
UnitedHealth Group
|
$599.47 | $635.32 | $548.3B | 38.68x | $2.10 | 1.4% | 1.39x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
ELV
Elevance Health
|
43.05% | 0.106 | 37.17% | 2.01x |
|
CI
The Cigna Group
|
43.79% | 0.375 | 42.17% | 0.77x |
|
CLOV
Clover Health Investments
|
-- | 4.133 | -- | 1.47x |
|
CNC
Centene
|
41.24% | 0.128 | 61.49% | 1.06x |
|
MOH
Molina Healthcare
|
39.4% | -0.134 | 17.93% | 1.56x |
|
UNH
UnitedHealth Group
|
45.36% | 0.784 | 16.27% | 0.75x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
ELV
Elevance Health
|
-- | -- | 8.66% | 14.4% | 2.08% | $384M |
|
CI
The Cigna Group
|
-- | -- | 4.6% | 8.07% | 3.61% | $4.9B |
|
CLOV
Clover Health Investments
|
$93.9M | -$21.4M | -13.55% | -13.55% | -6.38% | -$86.1M |
|
CNC
Centene
|
$3.7B | $175M | 7.38% | 12.3% | 1.27% | -$741M |
|
MOH
Molina Healthcare
|
$1.1B | $380M | 17.03% | 25.84% | 3.62% | -$235M |
|
UNH
UnitedHealth Group
|
$21.3B | $7.8B | 8.3% | 14.34% | 7.73% | $1.5B |
Elevance Health vs. Competitors
-
Which has Higher Returns ELV or CI?
The Cigna Group has a net margin of 0.92% compared to Elevance Health's net margin of 2.17%. Elevance Health's return on equity of 14.4% beat The Cigna Group's return on equity of 8.07%.
Company Gross Margin Earnings Per Share Invested Capital ELVElevance Health-- $1.81 $72.7B CIThe Cigna Group-- $5.13 $73.2B -
What do Analysts Say About ELV or CI?
Elevance Health has a consensus price target of $507.81, signalling upside risk potential of 15.46%. On the other hand The Cigna Group has an analysts' consensus of $364.13 which suggests that it could grow by 10.28%. Given that Elevance Health has higher upside potential than The Cigna Group, analysts believe Elevance Health is more attractive than The Cigna Group.
Company Buy Ratings Hold Ratings Sell Ratings ELVElevance Health14 3 0 CIThe Cigna Group13 7 0 -
Is ELV or CI More Risky?
Elevance Health has a beta of 0.773, which suggesting that the stock is 22.685% less volatile than S&P 500. In comparison The Cigna Group has a beta of 0.506, suggesting its less volatile than the S&P 500 by 49.385%.
-
Which is a Better Dividend Stock ELV or CI?
Elevance Health has a quarterly dividend of $1.71 per share corresponding to a yield of 1.5%. The Cigna Group offers a yield of 1.73% to investors and pays a quarterly dividend of $1.51 per share. Elevance Health pays 25.22% of its earnings as a dividend. The Cigna Group pays out 45.63% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ELV or CI?
Elevance Health quarterly revenues are $45.4B, which are smaller than The Cigna Group quarterly revenues of $65.7B. Elevance Health's net income of $418M is lower than The Cigna Group's net income of $1.4B. Notably, Elevance Health's price-to-earnings ratio is 17.17x while The Cigna Group's PE ratio is 26.98x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elevance Health is 0.58x versus 0.38x for The Cigna Group. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ELVElevance Health0.58x 17.17x $45.4B $418M CIThe Cigna Group0.38x 26.98x $65.7B $1.4B
-
Which has Higher Returns ELV or CLOV?
Clover Health Investments has a net margin of 0.92% compared to Elevance Health's net margin of -6.56%. Elevance Health's return on equity of 14.4% beat Clover Health Investments's return on equity of -13.55%.
Company Gross Margin Earnings Per Share Invested Capital ELVElevance Health-- $1.81 $72.7B CLOVClover Health Investments27.87% -$0.04 $341.1M -
What do Analysts Say About ELV or CLOV?
Elevance Health has a consensus price target of $507.81, signalling upside risk potential of 15.46%. On the other hand Clover Health Investments has an analysts' consensus of $4.75 which suggests that it could grow by 29.08%. Given that Clover Health Investments has higher upside potential than Elevance Health, analysts believe Clover Health Investments is more attractive than Elevance Health.
Company Buy Ratings Hold Ratings Sell Ratings ELVElevance Health14 3 0 CLOVClover Health Investments2 2 0 -
Is ELV or CLOV More Risky?
Elevance Health has a beta of 0.773, which suggesting that the stock is 22.685% less volatile than S&P 500. In comparison Clover Health Investments has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock ELV or CLOV?
Elevance Health has a quarterly dividend of $1.71 per share corresponding to a yield of 1.5%. Clover Health Investments offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Elevance Health pays 25.22% of its earnings as a dividend. Clover Health Investments pays out -- of its earnings as a dividend. Elevance Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ELV or CLOV?
Elevance Health quarterly revenues are $45.4B, which are larger than Clover Health Investments quarterly revenues of $337M. Elevance Health's net income of $418M is higher than Clover Health Investments's net income of -$22.1M. Notably, Elevance Health's price-to-earnings ratio is 17.17x while Clover Health Investments's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elevance Health is 0.58x versus 1.37x for Clover Health Investments. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ELVElevance Health0.58x 17.17x $45.4B $418M CLOVClover Health Investments1.37x -- $337M -$22.1M
-
Which has Higher Returns ELV or CNC?
Centene has a net margin of 0.92% compared to Elevance Health's net margin of 0.69%. Elevance Health's return on equity of 14.4% beat Centene's return on equity of 12.3%.
Company Gross Margin Earnings Per Share Invested Capital ELVElevance Health-- $1.81 $72.7B CNCCentene9.12% $0.56 $45B -
What do Analysts Say About ELV or CNC?
Elevance Health has a consensus price target of $507.81, signalling upside risk potential of 15.46%. On the other hand Centene has an analysts' consensus of $79.66 which suggests that it could grow by 24.75%. Given that Centene has higher upside potential than Elevance Health, analysts believe Centene is more attractive than Elevance Health.
Company Buy Ratings Hold Ratings Sell Ratings ELVElevance Health14 3 0 CNCCentene7 8 0 -
Is ELV or CNC More Risky?
Elevance Health has a beta of 0.773, which suggesting that the stock is 22.685% less volatile than S&P 500. In comparison Centene has a beta of 0.529, suggesting its less volatile than the S&P 500 by 47.066%.
-
Which is a Better Dividend Stock ELV or CNC?
Elevance Health has a quarterly dividend of $1.71 per share corresponding to a yield of 1.5%. Centene offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Elevance Health pays 25.22% of its earnings as a dividend. Centene pays out -- of its earnings as a dividend. Elevance Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ELV or CNC?
Elevance Health quarterly revenues are $45.4B, which are larger than Centene quarterly revenues of $40.8B. Elevance Health's net income of $418M is higher than Centene's net income of $283M. Notably, Elevance Health's price-to-earnings ratio is 17.17x while Centene's PE ratio is 10.23x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elevance Health is 0.58x versus 0.21x for Centene. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ELVElevance Health0.58x 17.17x $45.4B $418M CNCCentene0.21x 10.23x $40.8B $283M
-
Which has Higher Returns ELV or MOH?
Molina Healthcare has a net margin of 0.92% compared to Elevance Health's net margin of 2.39%. Elevance Health's return on equity of 14.4% beat Molina Healthcare's return on equity of 25.84%.
Company Gross Margin Earnings Per Share Invested Capital ELVElevance Health-- $1.81 $72.7B MOHMolina Healthcare10.6% $4.44 $7.4B -
What do Analysts Say About ELV or MOH?
Elevance Health has a consensus price target of $507.81, signalling upside risk potential of 15.46%. On the other hand Molina Healthcare has an analysts' consensus of $346.35 which suggests that it could grow by 0.39%. Given that Elevance Health has higher upside potential than Molina Healthcare, analysts believe Elevance Health is more attractive than Molina Healthcare.
Company Buy Ratings Hold Ratings Sell Ratings ELVElevance Health14 3 0 MOHMolina Healthcare6 7 0 -
Is ELV or MOH More Risky?
Elevance Health has a beta of 0.773, which suggesting that the stock is 22.685% less volatile than S&P 500. In comparison Molina Healthcare has a beta of 0.701, suggesting its less volatile than the S&P 500 by 29.866%.
-
Which is a Better Dividend Stock ELV or MOH?
Elevance Health has a quarterly dividend of $1.71 per share corresponding to a yield of 1.5%. Molina Healthcare offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Elevance Health pays 25.22% of its earnings as a dividend. Molina Healthcare pays out -- of its earnings as a dividend. Elevance Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ELV or MOH?
Elevance Health quarterly revenues are $45.4B, which are larger than Molina Healthcare quarterly revenues of $10.5B. Elevance Health's net income of $418M is higher than Molina Healthcare's net income of $251M. Notably, Elevance Health's price-to-earnings ratio is 17.17x while Molina Healthcare's PE ratio is 16.89x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elevance Health is 0.58x versus 0.49x for Molina Healthcare. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ELVElevance Health0.58x 17.17x $45.4B $418M MOHMolina Healthcare0.49x 16.89x $10.5B $251M
-
Which has Higher Returns ELV or UNH?
UnitedHealth Group has a net margin of 0.92% compared to Elevance Health's net margin of 5.5%. Elevance Health's return on equity of 14.4% beat UnitedHealth Group's return on equity of 14.34%.
Company Gross Margin Earnings Per Share Invested Capital ELVElevance Health-- $1.81 $72.7B UNHUnitedHealth Group21.14% $5.98 $179.5B -
What do Analysts Say About ELV or UNH?
Elevance Health has a consensus price target of $507.81, signalling upside risk potential of 15.46%. On the other hand UnitedHealth Group has an analysts' consensus of $635.32 which suggests that it could grow by 5.98%. Given that Elevance Health has higher upside potential than UnitedHealth Group, analysts believe Elevance Health is more attractive than UnitedHealth Group.
Company Buy Ratings Hold Ratings Sell Ratings ELVElevance Health14 3 0 UNHUnitedHealth Group20 1 0 -
Is ELV or UNH More Risky?
Elevance Health has a beta of 0.773, which suggesting that the stock is 22.685% less volatile than S&P 500. In comparison UnitedHealth Group has a beta of 0.607, suggesting its less volatile than the S&P 500 by 39.293%.
-
Which is a Better Dividend Stock ELV or UNH?
Elevance Health has a quarterly dividend of $1.71 per share corresponding to a yield of 1.5%. UnitedHealth Group offers a yield of 1.4% to investors and pays a quarterly dividend of $2.10 per share. Elevance Health pays 25.22% of its earnings as a dividend. UnitedHealth Group pays out 52.29% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ELV or UNH?
Elevance Health quarterly revenues are $45.4B, which are smaller than UnitedHealth Group quarterly revenues of $100.8B. Elevance Health's net income of $418M is lower than UnitedHealth Group's net income of $5.5B. Notably, Elevance Health's price-to-earnings ratio is 17.17x while UnitedHealth Group's PE ratio is 38.68x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elevance Health is 0.58x versus 1.39x for UnitedHealth Group. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ELVElevance Health0.58x 17.17x $45.4B $418M UNHUnitedHealth Group1.39x 38.68x $100.8B $5.5B
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Bloom Energy Stock a Buy, Sell or Hold?
While already interesting as the world moves toward greener energy…
What Do Tesla Delivery Numbers Mean for Tesla Stock?
Tesla (NASDAQ:TSLA) released Q1 delivery numbers, showing a substantial slowdown…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
50
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
52
RGC alert for Apr 12
Regencell Bioscience Holdings [RGC] is up 29.14% over the past day.
Buy
52
SLP alert for Apr 12
Simulations Plus [SLP] is up 26.73% over the past day.
Buy
89
GDXU alert for Apr 12
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 15.9% over the past day.
